TriApex Laboratories
Contract research enabling disease-oriented drug development services.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Series C | |
| Total Funding | 000k | ||
TriApex Laboratories Co., Ltd. is a contract research organization (CRO) founded in 2008 that provides integrated research and development services to global pharmaceutical companies and research institutions. The company is headquartered in Nanjing, China, with subsidiaries in Kunming, Shanghai, Chengdu, Hainan, and a bioanalytical laboratory in Philadelphia, Pennsylvania, in the US.
The firm's business is structured into three main segments: disease model and pharmacodynamics research, pharmaceutical policy strategy and safety assessment, and clinical and laboratory services. TriApex specializes in disease-oriented R&D, with a focus on ophthalmology, central nervous system (CNS) disorders, and metabolic diseases. Its services cover the entire drug development lifecycle, from early discovery and non-clinical research to clinical trials and regulatory submissions for bodies like the NMPA and FDA. Key service offerings include pharmacokinetics, drug safety assessment, bioanalysis, biomarker analysis, and support for clinical trials. The company serves a client base that includes leading pharmaceutical and biotech companies in China, Europe, and the United States, and has collaborated with top 20 international pharmaceutical enterprises.
TriApex has received Series C funding, led by Legend Capital, to accelerate its international expansion and enhance its R&D services. The company holds certifications such as NMPA GLP and accreditation from AAALAC International.
Keywords: contract research organization, drug development, non-clinical research, clinical trials, pharmaceutical services, bioanalysis, pharmacokinetics, safety assessment, regulatory strategy, disease models, ophthalmology R&D, CNS research, metabolic disease research, translational medicine, biomarker analysis, pharmaceutical outsourcing, preclinical studies, clinical pharmacology, bioanalytical services, drug discovery services
